Viva Biotech Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Viva Biotech Holdings has a total shareholder equity of CN¥3.7B and total debt of CN¥1.9B, which brings its debt-to-equity ratio to 50.7%. Its total assets and total liabilities are CN¥7.4B and CN¥3.8B respectively. Viva Biotech Holdings's EBIT is CN¥192.7M making its interest coverage ratio 1.3. It has cash and short-term investments of CN¥1.0B.
Key information
50.7%
Debt to equity ratio
CN¥1.87b
Debt
| Interest coverage ratio | 1.3x |
| Cash | CN¥1.04b |
| Equity | CN¥3.69b |
| Total liabilities | CN¥3.76b |
| Total assets | CN¥7.45b |
Recent financial health updates
Does Viva Biotech Holdings (HKG:1873) Have A Healthy Balance Sheet?
Jun 01
These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt In A Risky Way
Sep 25These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt Extensively
Apr 14Is Viva Biotech Holdings (HKG:1873) Using Too Much Debt?
Nov 06We Think Viva Biotech Holdings (HKG:1873) Is Taking Some Risk With Its Debt
Apr 17Recent updates
Positive Sentiment Still Eludes Viva Biotech Holdings (HKG:1873) Following 27% Share Price Slump
Jan 19Does Viva Biotech Holdings (HKG:1873) Have A Healthy Balance Sheet?
Jun 01These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt In A Risky Way
Sep 25Is It Too Late To Consider Buying Viva Biotech Holdings (HKG:1873)?
Jul 11These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt Extensively
Apr 14Is Now The Time To Look At Buying Viva Biotech Holdings (HKG:1873)?
Dec 23Is Viva Biotech Holdings (HKG:1873) Using Too Much Debt?
Nov 06Estimating The Intrinsic Value Of Viva Biotech Holdings (HKG:1873)
Jun 13We Think Viva Biotech Holdings (HKG:1873) Is Taking Some Risk With Its Debt
Apr 17Viva Biotech Holdings (HKG:1873) Shareholders Have Enjoyed A 55% Share Price Gain
Mar 13Need To Know: Viva Biotech Holdings (HKG:1873) Insiders Have Been Selling Shares
Feb 06What Percentage Of Viva Biotech Holdings (HKG:1873) Shares Do Insiders Own?
Jan 02Can You Imagine How Viva Biotech Holdings' (HKG:1873) Shareholders Feel About The 65% Share Price Increase?
Nov 21
Financial Position Analysis
Short Term Liabilities: 1873's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 1873's short term assets (CN¥2.0B) do not cover its long term liabilities (CN¥2.2B).
Debt to Equity History and Analysis
Debt Level: 1873's net debt to equity ratio (22.6%) is considered satisfactory.
Reducing Debt: 1873's debt to equity ratio has reduced from 88.7% to 50.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 1873 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1873 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.